[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
April 2001

Newly Recognized Complications of Posterior Chamber Intraocular Lenses

Arch Ophthalmol. 2001;119(4):581-582. doi:10.1001/archopht.119.4.581

THREE SIGNIFICANT postoperative complications of intraocular lens (IOL) surgery have recently emerged.14 Although these complications often threaten patients' vision, overall they have received little publicity, especially in the United States. In this issue of the ARCHIVES, Yu and Shek1 report one of these complications, an unexpected late postoperative opacification on the optical component of a modern foldable hydrophilic IOL, the Hydroview lens(Bausch & Lomb Surgical, Claremont, Calif). This lens has been approved by several regulatory agencies and has been implanted extensively outside of the United States. Although in 1999 it was approved by the Food and Drug Administration for use in the United States, it has not yet been marketed in this country because the manufacturer is searching for a better understanding of the problem reported by Yu and Shek. These authors are the first to identify this complication in a clinical setting. We have concurrently and independently studied this lens and have recently published a clinicopathologic report on the first 5 explants received in our laboratory.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×